stars 1 stars 2 stars 3

Syngene provides instruments, software and systems for documenting and analysing gels used by molecular biologists in genomic and proteomic studies. Almost all research in the biological sciences involves understanding the underlying molecular processes involving DNA, RNA and proteins, and gel electrophoresis is a fundamental process in many laboratories working in this area. Syngene are industry experts, providing optical imaging to suit your needs. Syngene products range from low-cost entry-level kits to fully computer-controlled automatic analysers for fluorescence, chemiluminescence and proteomics workstations. • Gel documentation (gel doc) and image analysis systems for DNA and protein gels. • Chemiluminescence and fluorescence systems for Western blots and probes. • Proteomics hardware and software for 2D gel electrophoresis (2DGE). We are headquartered in Cambridge, a thriving scientific hub in the UK and have a centrally located US subsidiary in Frederick, USA. Globally, our products are supported by an international network of highly-trained distributors, all of whom employ imaging specialists.

Syngene Questions

The Syngene annual revenue was $402.3 million in 2026.

27 people are employed at Syngene.

The NAICS codes for Syngene are [541711, 541, 54, 54171, 5417].

The SIC codes for Syngene are [386, 3861, 38].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users